XML 34 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (37,030) $ (84,812)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 11,170 2,397
Inventory impairment charges 1,192 78
Share-based compensation 30,845 14,185
Amortization of discount of debt 226 198
Bad debts 24 125
Gain from change in fair value remeasurement of SAFEs 0 (21,600)
(Gain) loss from change in fair value of warrants (48,595) 29,085
Loss from change in fair value of earn-out liabilities 0 27,557
(Gain) loss from change in fair value of contingent considerations (3,546) 120
(Gain) loss from change in fair value of currency forward contract (211) 1,200
Gain from extinguishment of debt 0 (304)
Deferred City Semi compensation 203 375
Deferred tax liabilities 1,532 0
Amortization of right-of-use assets 1,463 0
Changes in operating assets and liabilities:    
Accounts receivable (8,854) (3,047)
Inventory (2,406) (2,730)
Accounts payable 2,945 625
Accrued expenses and other current liabilities 1,587 2,578
Accrued payroll liabilities (843) 236
Deferred revenue 93 (1,113)
Prepaid and other current assets (6,129) (2,848)
Operating lease liabilities (1,159) 0
Other long-term liabilities (1,322) 782
Net cash used in operating activities (58,815) (36,913)
Cash flows from investing activities:    
Purchases of property and equipment (4,508) (1,668)
Purchases of intangible assets 0 (784)
Business combinations, net of cash (8,705) 0
Net cash used in investing activities (13,213) (2,452)
Cash flows from financing activities:    
Proceeds from issuance of SAFEs 0 5,000
Proceeds from issuance of common stock/At-the-market offering 12,273 0
Offering costs for the issuance of common stock/At-the-market offering (273) 0
Proceeds from issuance of debt obligations 1,059 155
Proceeds from reverse recapitalization 0 377,663
Issuance costs related to reverse recapitalization 0 (19,902)
Payments on debt obligations (1,404) (15,008)
Payments on financed software (3,224) (2,270)
Redemption of Class H units 0 (900)
Payments on business combination (5,000) 0
Payments of City Semi deferred compensation (1,000) (399)
Proceeds from exercise of stock options 100 0
Net cash provided by financing activities 2,531 344,339
Effect of exchange rate changes on cash and cash equivalents 804 193
Net increase (decrease) in cash and cash equivalents (68,693) 305,167
Cash, cash equivalents and restricted cash at beginning of period 219,464 18,698
Cash, cash equivalents and restricted cash at end of period 150,771 323,865
Supplemental disclosure of cash flow information:    
Cash paid for interest 218 1,188
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment, accrued but not paid 275 206
Conversion of historical members' equity 0 41,278
Class G warrants cashless exchange 0 407
Conversion of SAFEs 0 86,100
Conversion of Embry Notes 0 4,119
Recognition of earn-out considerations 0 119,759
Accrual for purchases of intangible assets 0 12,198
Recognition of warrant liabilities 0 74,408
Contingent consideration for business combination 8,204 0
Accrual for purchase consideration for business combination $ 9,674 $ 0